查詢結果分析
相關文獻
- Perinatal Management of Pregnancy with Human Immunodeficiency Virus Infection: A Case Report of Antenatal Antiviral Therapy and Elective Cesarean Delivery to Reduce the Risk of Vertical Transmission
- Concomitant Digestive Malignancy in Pregnancy
- 臺灣愛滋病毒母子垂直感染之流行病學
- 懷孕婦女使用抗反轉錄病毒藥物之安全性
- 防止愛滋病毒母子垂直感染之治療建議
- 臺灣愛滋病毒母子垂直感染個案之分析探討
- 產科護理人員對愛滋病毒篩檢孕婦之照護的知識
- Unusual Presentation of Heterotopic Pregnancy: A Case Report
- Reopening of Patent Urachus during Pregnancy
- Delayed Postpartum Hemorrhage in Adenomyosis: A Case Report
頁籤選單縮合
題 名 | Perinatal Management of Pregnancy with Human Immunodeficiency Virus Infection: A Case Report of Antenatal Antiviral Therapy and Elective Cesarean Delivery to Reduce the Risk of Vertical Transmission=妊娠合併愛滋病毒感染之週產期處理:產前使用抗病毒藥劑治療以及選擇性剖腹產以降低垂直感染之危險性 |
---|---|
作 者 | 王培中; 張炯心; 游振祥; 曾斌宏; 張峰銘; | 書刊名 | 中華民國婦產科醫學會會刊雜誌 |
卷 期 | 38:3 1999.09[民88.09] |
頁 次 | 頁97-102 |
分類號 | 417.42 |
關鍵詞 | 妊娠; 愛滋病毒; 週產期處理; 垂直感染; Pregnancy; Human immunodeficiency virus infection; Vertical transmission; |
語 文 | 英文(English) |
中文摘要 | 背景:產前使用抗病毒藥劑以及選擇何種方式分娩,對降低第一型愛滋病毒之垂直感染十分重要。我們報告一例妊娠合併愛滋病毒感染之週產期處理。產前我們使用抗病毒藥治療以及選擇性剖腹產以降低垂直感染之危險性。 病例報告:一位二十四歲高棉新娘感染愛滋病毒,於妊娠21週時被地區衛生單位檢出,於妊娠32週時轉送至本院進一步治療。自33週到分娩之間,我們給予zidovudine(AZT)每天500毫克。於39週分娩時,我們採用選擇性剖腹生產。整個過程十分順利,此產婦恢復正常,於四天後出院。其男嬰亦健康出生,現仍接受小兒科之抗病毒藥劑治療中,至少到目前為止,此男嬰無感染愛滋病毒之現象。 結論:產前使用抗愛滋病毒藥劑以及選擇性剖腹產可以降低愛滋病毒之垂直感染的危險性。由西方國家最新的文獻,以及我們這例經驗,我們建議使用以上兩種方法來降低愛滋病毒垂直感染的機會。 |
英文摘要 | BACKGROUND: Antenatal antiretroviral therapy and the mode of delivery in women with human immunodeficiency virus (HIV) type 1 infection are very crucial in preventing vertical transmission of HIV. We present a case receiving prenatal zidovudine (AZT) therapy and elective cesarean delivery in an attempt to reduce the risk of vertical transmission. CASE REPORT: A 24-year-old Cambodian woman with HIV infection, detected by local doctors at 21 weeks of gestation, was referred to our hospital at 32 weeks of gestation. She received AZT 500 mg QD from 33 weeks of gestation to delivery. We performed a cesarean delivery at 39 weeks of gestation. The procedure was done uneventfully and the patient recovered without any complications. Her male baby was live and well at parturition and has subsequently been treated continuously with antiviral agents by pediatricians. To the present (2 months of age), the newborn has grown well without evidence of HIV infection. CONCLUSIONS: Ideal treatment with antenatal AZT therapy may begin from the beginning of gestation. However, receiving antenatal antiviral agents from 33 weeks of gestation and elective cesarean delivery may still reduce the risk of vertical transmission of HIV. From our case and recent reports from Western countries, we advocate that these two regimens should be undertaken in order to lower the risk of vertical transmission of HIV. |
本系統中英文摘要資訊取自各篇刊載內容。